Skip to content

Role of Homoeopathic Medicines in the treatment of Cluster Headache

Usefulness of Individualised Homoeopathic Intervention in the treatment of Cluster Headache- An Exploratory Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039289
Enrollment
21
Registered
2022-01-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G440- Cluster headaches and other trigeminal autonomic cephalgias (TAC)

Interventions

Intervention1: Individualised Homoeopathic Medicine based on case taking. : Individualised Homoeopathic Intervention Route of Administration- oral In the form of Pills. 30 Pill size. Potency- 30C, 200

Sponsors

Bakson Homoeopathic Medical Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: According to the criteria of the (ICHD) International Classification of Headache Disorders, at least 5 attacks meeting the following are required for diagnosis: 1. Severe unilateral, orbital (around the eye) and/or temporal (around the temple) pain lasting 15-180 minutes if untreated. 2. Attacks have a frequency from one every other to 8 per day. Headache must be accompanied by at least one of the following: 1. Red eye or tearing on the side of the headache 2. Nasal congestion or runny nose on the side of the headache 3. Eyelid swelling on the side of the headache 4. Forehead and facial sweating on the side of the headache 5. Small pupil or eyelid droop on the side of the headache 6. A sense of restlessness or agitation

Exclusion criteria

Exclusion criteria: 1. Migraine 2. Patients with other types of headache. (e.g. Post Traumatic Headaches, Tension Headache). 3. Headaches related to hypertension or any other comorbidity, (comorbidities: Chronic Headache, Arterial Hypertension).

Design outcomes

Primary

MeasureTime frame
It is expected that 1. Positive response:- Symptomatic score changed on HIT Scale and VAS towards improvement. 2. Negative response :- Symptomatic Score changed on HIT Scale and VAS towards worsening. 3. Status Quo:- No change in the symptomatic score on HIT scale and VAS and no relief in complaints. Timepoint: 12 Months

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Mansi Chawla

Bakson Homoeopathic Medical College & Hospital

r3277236@gmail.com9664009121

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026